San Antonio-based Diagnostics Research Group Tests New Treatments for COPD

Diagnostics Research Group is seeking individuals with COPD for an upcoming study.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

San Antonio, TX (PRWEB) April 10, 2013

Diagnostics Research Group, an independent site for pharmaceutical and device research, is working with pharmaceutical companies to assess COPD (Chronic Obstructive Pulmonary Disease) medications currently not available to the public.

COPD is the third leading cause of death in the United States. Chronic Bronchitis and Emphysema are two forms of COPD. Both of these conditions demonstrate deterioration of the lungs and may eventually cause heart problems if left untreated. COPD sufferers will have shortness of breath and may eventually need oxygen supply.

Smoking is the main cause of COPD and causes about 85 to 90 percent of COPD deaths. COPD is most often seen in men and women age 45 and older who have a history of smoking. Stopping smoking can improve the symptoms of COPD, but will not cause total reversal of the condition. There are many medications available on the market today that help to relieve the symptoms associated with COPD, but none that have cured the disease.

Charles P. Andrews, MD, CPI and John R. Holcomb, MD, CPI are Principal Investigators at Diagnostics Research Group and have been researching COPD for the past 12 years. They are both board certified lung specialists and certified investigators with more than 30 years of experience in clinical research and respiratory disorders. Along with their staff of Certified Research Coordinators, Drs. Andrews and Holcomb have conducted over 200 clinical research studies, with more than half of the studies in the areas of lung disorders.

Currently, Diagnostics Research Group is looking for men and women, age 40 and older to participate in an upcoming clinical trial researching an investigational COPD medication. Participants will receive study-related medical care at no cost, study medication at no cost and will be compensated for their time and travel.

Persons who are interested in participating in the upcoming COPD trial may contact Diagnostics Research Group at 210-692-7157 or by visiting their web site at http://www.dxrg.com for more information.

About the company:
Diagnostics Research Group, located in the South Texas Medical Center in San Antonio, Texas, is an independent clinical research site that performs clinical trials to test the safety and effectiveness of new drugs, treatments, and medical devices.

Those interested in volunteering for clinical studies can expect quality care from the staff at Diagnostics Research Group. Currently, there are 10 staff members certified by the Association of Clinical Research Professionals. Diagnostics Research Group has research experience with more than 200 studies in several therapeutic areas such as: allergy studies, respiratory diseases, internal medicine, women’s health, vaccines, and sleep disorders.


Contact